potential income9 Feb 2023 08:18
from AHIL alone was in the region of £5m for the UK. The US market is 5x bigger. The rest of teh world - EU, Middle East, Asia, Far East.... The potential is certainly £50m per year and that's not an exaggeration.
But wait, yo've then got the Stroke marker test to follow, which, given GDR's profile and visibility will go through the roof as a result of today's news from NICE, will be easier to reach market. So double £50m per year of income at least and you're somewhere close to realising what can happen here.
This is not to mention anything else GDR have up their sleeve. Suddenly the tech they own will be very tempting to pharmas. My personal hope is that a pharma comes along and snaps up the lot for about £100m. More? who knows. Game on.